Clinical Trial Update: Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating VHX-896 in combination with iloperidone tablets under steady-state conditions; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Iloperidone (iloperidone)
• VHX-896

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Schizophrenia, Bipolar I Disorder | Phase 1 | Status: COMPLETED